Big Market Beckons As Celsion’s China ThermaDox Plans Advance

Celsion expects a regulatory clearance for Chinese sites to participate in its ongoing international Phase III trial with ThermoDox to accelerate the development of the drug in China, where the company aims to bring the doxorubicin preparation into the world’s largest liver cancer market through a manufacturing partnership with Hisun and a possible future commercial partner.